ACHR MYASTHENIA GRAVIS

Clinical trials for ACHR MYASTHENIA GRAVIS explained in plain language.

Never miss a new study

Get alerted when new ACHR MYASTHENIA GRAVIS trials appear

Sign up with your email to follow new studies for ACHR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for myasthenia gravis: experimental drug CNP-106 enters human trials

Disease control Ongoing

This study tests an experimental drug called CNP-106 in 54 adults aged 18-75 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to check if the drug is safe and how it affects the immune system. Participants receive either CNP-106 or a placeb…

Matched conditions: ACHR MYASTHENIA GRAVIS

Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

ACHR MYASTHENIA GRAVIS

Get alerted when new ACHR MYASTHENIA GRAVIS trials appear

New hope for myasthenia gravis: experimental drug CNP-106 enters human trials